Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 1.8B | 1.8B | 1.6B |
Cost of revenue | 1.3B | 1.1B | 962M | 1.0B |
Gross profit | 1.4B | 641M | 840M | 587M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | -9M |
Other operating expenses | — | — | — | — |
Operating income | 925M | 243M | 437M | 188M |
Non operating interest income | ||||
Income | — | 5M | 9M | 9M |
Expense | 255M | 243M | 246M | 243M |
Other income expense | 50M | -31M | -186M | 214M |
Pretax income | 720M | -26M | 14M | 168M |
Tax provision | 119M | -199M | -9M | 21M |
Net income | 601M | 173M | 23M | 147M |
Basic EPS | 2.0 | — | 0.0 | 0.5 |
Diluted EPS | 2.0 | — | 0.0 | 0.5 |
Basic average shares | 413.8M | — | 404.1M | 400.3M |
Diluted average shares | 414.2M | — | 404.2M | 400.4M |
EBITDA | 1.3B | 572M | 783M | 529M |
Net income from continuing op. | 601M | 173M | 23M | 147M |
Minority interests | — | 0 | -1M | — |
Preferred stock dividends | — | — | — | — |